US3385756A
(en)
|
1965-06-07 |
1968-05-28 |
Monsanto Co |
Methods of destroying insects with nitro-substituted salicylanilides
|
US3975532A
(en)
|
1973-06-14 |
1976-08-17 |
Ici United States Inc. |
Hexahydro-1H-furo(3,4-c) pyrrole compounds for treating pain
|
DE2853220A1
(de)
|
1978-12-09 |
1980-07-03 |
Hoechst Ag |
Neue amino-pyrimidin-carbanilide, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
|
US4507481A
(en)
|
1983-07-29 |
1985-03-26 |
Pennwalt Corporation |
Pyrrolo[1,2-a]imidazoles and imidazo[1,2-a]pyridines
|
US4917826A
(en)
|
1985-10-18 |
1990-04-17 |
The Upjohn Company |
Cyclic hydrocarbons with an aminoalkyl sidechain
|
US5656644A
(en)
|
1994-07-20 |
1997-08-12 |
Smithkline Beecham Corporation |
Pyridyl imidazoles
|
JP2609434B2
(ja)
|
1992-11-16 |
1997-05-14 |
ボリソビッチ レオニドフ,ニコライ |
抗菌性インターフェロン誘発性医薬品
|
GB9315595D0
(en)
|
1993-07-28 |
1993-09-08 |
Res Inst Medicine Chem |
New compounds
|
US5508269A
(en)
|
1994-10-19 |
1996-04-16 |
Pathogenesis Corporation |
Aminoglycoside formulation for aerosolization
|
US6083922A
(en)
|
1996-04-02 |
2000-07-04 |
Pathogenesis, Corp. |
Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
|
US5767068A
(en)
|
1997-02-13 |
1998-06-16 |
Pathogenesis Corporation |
Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
|
FR2765577A1
(fr)
|
1997-07-02 |
1999-01-08 |
Hoechst Schering Agrevo Sa |
Nouveaux amides aromatiques, leur procede de preparation et leur application comme pesticides
|
GB9805520D0
(en)
|
1998-03-17 |
1998-05-13 |
Zeneca Ltd |
Chemical compounds
|
DE19817262A1
(de)
|
1998-04-18 |
1999-10-21 |
Bayer Ag |
Neue 2-heterocyclisch substituierte Dihydropyrimidine
|
US6525069B1
(en)
|
1998-12-18 |
2003-02-25 |
Bristol-Myers Squibb Pharma Co. |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
CA2359244C
(en)
|
1999-01-13 |
2013-10-08 |
Bayer Corporation |
.omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
|
US6498165B1
(en)
|
1999-06-30 |
2002-12-24 |
Merck & Co., Inc. |
Src kinase inhibitor compounds
|
DE10012549A1
(de)
|
2000-03-15 |
2001-09-20 |
Bayer Ag |
Arzneimittel gegen virale Erkrankungen
|
DE10012823A1
(de)
|
2000-03-16 |
2001-09-20 |
Bayer Ag |
Arzneimittel gegen virale Erkrankungen
|
DE10013126A1
(de)
|
2000-03-17 |
2001-09-20 |
Bayer Ag |
Arzneimittel gegen virale Erkrankungen
|
WO2002053543A1
(fr)
|
2000-12-28 |
2002-07-11 |
Shionogi & Co., Ltd. |
Derive de pyridone ayant une affinite pour le recepteur cannabinoide de type 2
|
AU2003273179A1
(en)
|
2002-05-10 |
2003-12-12 |
Bristol-Myers Squibb Company |
1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors
|
MXPA05000947A
(es)
|
2002-07-25 |
2005-05-16 |
Pharmacia Italia Spa |
Biciclo-pirazoles activos como inhibidores de cinasa, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
|
US20050113450A1
(en)
|
2002-08-23 |
2005-05-26 |
Atli Thorarensen |
Antibacterial agents
|
US20040209930A1
(en)
|
2002-10-02 |
2004-10-21 |
Carboni Joan M. |
Synergistic methods and compositions for treating cancer
|
DE10257358A1
(de)
|
2002-12-09 |
2004-07-08 |
Bayer Healthcare Ag |
Substituierte Pyrrole
|
US7232825B2
(en)
|
2003-05-02 |
2007-06-19 |
Guoqing P Chen |
Phenylaminopyrimidine derivatives and methods of use
|
TW200519091A
(en)
|
2003-09-10 |
2005-06-16 |
Synta Pharmaceuticals Corp |
Dihydropyridine compounds for treating or preventing metabolic disorders
|
ES2562778T3
(es)
|
2003-12-02 |
2016-03-08 |
The Ohio State University Research Foundation |
Ácidos grasos de cadena corta unidos a motivos quelantes de Zn2+ como una clase novedosa de inhibidores de histona deacetilasa
|
KR20070083484A
(ko)
|
2004-07-14 |
2007-08-24 |
피티씨 테라퓨틱스, 인크. |
C형 간염 치료 방법
|
WO2006033995A2
(en)
|
2004-09-16 |
2006-03-30 |
Valeant Research And Development |
Thiazolidin-4-ones having anti-hepatitis b activity
|
EP1904452A2
(en)
|
2005-07-14 |
2008-04-02 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
EP1922068A4
(en)
|
2005-08-16 |
2010-08-11 |
Icagen Inc |
INHIBITORS OF VOLTAGE-CONTROLLED SODIUM CHANNELS
|
WO2008054454A2
(en)
|
2006-02-10 |
2008-05-08 |
Transtech Pharma, Inc. |
Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
|
JP5153777B2
(ja)
|
2006-10-02 |
2013-02-27 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
タンパク質キナーゼとしての化合物および組成物
|
WO2008120759A1
(ja)
|
2007-03-30 |
2008-10-09 |
Japan Tobacco Inc. |
ウレア化合物およびその用途
|
TWI394575B
(zh)
|
2007-07-09 |
2013-05-01 |
Golden Biotechnology Corp |
Application of Cynanchum auranthone Cyclohexenone Compounds in the Preparation of Drugs for the Suppression of Hepatitis B Virus
|
US8124610B2
(en)
|
2007-07-13 |
2012-02-28 |
Icagen Inc. |
Sodium channel inhibitors
|
CA2695071A1
(en)
|
2007-08-02 |
2009-02-05 |
F. Hoffmann-La Roche Ag |
The use of benzamide derivatives for the treatment of cns disorders
|
CN102099351A
(zh)
|
2007-11-16 |
2011-06-15 |
先灵公司 |
3-杂环取代的吲哚衍生物及其使用方法
|
EP2280001B1
(en)
|
2008-04-24 |
2014-10-15 |
Msd K.K. |
Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
|
CN102131801B
(zh)
|
2008-06-25 |
2015-04-08 |
福拉姆医药股份有限公司 |
1,2-二取代的杂环化合物
|
US8101643B2
(en)
|
2009-02-27 |
2012-01-24 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
WO2011008597A1
(en)
|
2009-07-14 |
2011-01-20 |
Schering Corporation |
Dihydroimidazoisoquinoline derivatives useful as pde10 inhibitors
|
US20110281950A1
(en)
|
2010-05-11 |
2011-11-17 |
Baiocchi Robert A |
Compositions and methods for reducing proliferation and viability of lymphoblastoid cells
|
EP2726459B1
(en)
|
2011-07-01 |
2019-09-11 |
Baruch S. Blumberg Institute |
Sulfamoylbenzamide derivatives as antiviral agents against hbv infection
|
MX359634B
(es)
|
2011-12-21 |
2018-10-03 |
Novira Therapeutics Inc |
Agentes antivirales contra la hepatitis b.
|
EA026977B1
(ru)
|
2012-01-06 |
2017-06-30 |
Янссен Сайенсиз Айрлэнд Юси |
4,4-дизамещенные 1,4-дигидропиримидины и их применение в качестве лекарственных препаратов для лечения гепатита b
|
SG10201605325TA
(en)
|
2012-01-13 |
2016-08-30 |
Nippon Chemiphar Co |
P2x4 receptor antagonist
|
BR112014021498A2
(pt)
|
2012-02-29 |
2017-07-18 |
Institute For Hepatitis And Virus Res |
composto, composição e método para tratar uma doença associada com formação de dna circular covalentemente fechado
|
US20130267517A1
(en)
|
2012-03-31 |
2013-10-10 |
Hoffmann-La Roche Inc. |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
WO2013144129A1
(en)
|
2012-03-31 |
2013-10-03 |
F. Hoffmann-La Roche Ag |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
CA2874828A1
(en)
|
2012-06-01 |
2013-12-05 |
Drexel University |
Modulation of hepatitis b virus cccdna transcription
|
HUE034919T2
(en)
|
2012-08-24 |
2018-03-28 |
Sunshine Lake Pharma Co Ltd |
2,4,5,6-substituted 3,6-dihydropyrimidine derivatives such as hepatitis B virus (HBV) polymerase inhibitors, for example, for the treatment of chronic hepatitis
|
JOP20130256B1
(ar)
|
2012-08-28 |
2021-08-17 |
Janssenٍ Sciences Ireland Uc |
مركبات سلفامويل اريل اميدات واستعمالها كمواد علاجية لمعالجة التهاب الكبد نوع بي
|
PE20150776A1
(es)
|
2012-09-10 |
2015-05-21 |
Hoffmann La Roche |
6-aminoacido-heteroarildihidropirimidinas para el tratamiento y profilaxis de la infeccion del virus de la hepatitis b
|
HUE056251T2
(hu)
|
2012-10-25 |
2022-02-28 |
Tetra Discovery Partners Llc |
Heteroaril PDE4 inhibitorok
|
EA201591220A1
(ru)
|
2012-12-27 |
2016-01-29 |
Дрексел Юниверсити |
Новые противовирусные агенты против инфекции вирусом гепатита в
|
JO3603B1
(ar)
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
|
AU2014267198A1
(en)
|
2013-05-17 |
2015-11-05 |
F. Hoffmann-La Roche Ag |
6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of Hepatitis B virus infection
|
SI2997019T1
(sl)
|
2013-05-17 |
2018-12-31 |
Janssen Sciences Ireland Uc, |
Derivati sulfamoiliofenamida in njihova uporaba kot zdravila za zdravljenje hepatitisa B
|
JP6748431B2
(ja)
|
2013-07-12 |
2020-09-02 |
京都ケミカル株式会社 |
抗菌剤、袋入り抗菌剤およびシート型抗菌剤
|
CN103398548B
(zh)
|
2013-07-29 |
2016-01-20 |
蔡京鹏 |
一种汽化热可大部回收利用的烘干、干馏或热解方法及装置
|
TW201605859A
(zh)
|
2013-11-14 |
2016-02-16 |
必治妥美雅史谷比公司 |
作為酪蛋白激酶1δ/ε抑制劑之新穎經取代之吡唑并-哌
|
KR20160077050A
(ko)
|
2013-11-19 |
2016-07-01 |
선샤인 레이크 파르마 컴퍼니 리미티드 |
다이하이드로피리미딘 화합물 및 이의 약제학적 용도
|
AU2014356984B2
(en)
|
2013-11-27 |
2018-01-04 |
Sunshine Lake Pharma Co., Ltd. |
Processes for preparing dihydropyrimidine derivatives and intermediates thereof
|
US9435197B2
(en)
|
2014-01-14 |
2016-09-06 |
Baker Hughes Incorporated |
Distributed marinized borehole system
|
US9169212B2
(en)
|
2014-01-16 |
2015-10-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
EP3099685B1
(en)
|
2014-01-30 |
2018-04-18 |
F.Hoffmann-La Roche Ag |
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
|
CR20160337A
(es)
|
2014-03-07 |
2016-09-20 |
Hoffmann La Roche |
Nuevas heteroarildihidropirimidinas 6-fusionadas para el tratamiento y la profilaxis de la infección por virus de la hepatitis b
|
SG11201605896WA
(en)
|
2014-03-28 |
2016-08-30 |
Sunshine Lake Pharma Co Ltd |
Dihydropyrimidine compounds and their application in pharmaceuticals
|
WO2015173164A1
(en)
|
2014-05-13 |
2015-11-19 |
F. Hoffmann-La Roche Ag |
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
|
BR112016028000B1
(pt)
|
2014-05-30 |
2022-05-17 |
Qilu Pharmaceutical Co., Ltd |
Derivado de alça de di-hidropirimido como um inibidor de hbv
|
WO2016016370A1
(en)
|
2014-07-31 |
2016-02-04 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Flt3 receptor antagonists
|
EP3180319B1
(en)
|
2014-08-14 |
2018-10-03 |
F.Hoffmann-La Roche Ag |
Novel pyridazones and triazinones for the treatment and prophylaxis of hepatitis b virus infection
|
WO2016025933A2
(en)
|
2014-08-15 |
2016-02-18 |
Ptc Therapeutics, Inc. |
Substituted polycyclic antibacterial compounds
|
US9637485B2
(en)
|
2014-11-03 |
2017-05-02 |
Hoffmann-La Roche Inc. |
6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection
|
CN107108610B
(zh)
|
2014-12-30 |
2019-06-04 |
豪夫迈·罗氏有限公司 |
用于治疗和预防肝炎b病毒感染的新的四氢吡啶并嘧啶和四氢吡啶并吡啶化合物
|
RU2742305C2
(ru)
|
2014-12-30 |
2021-02-04 |
Новира Терапьютикс, Инк. |
Производные и способы лечения инфекций гепатита в
|
CN107207505B
(zh)
|
2015-02-11 |
2018-12-14 |
豪夫迈·罗氏有限公司 |
治疗和预防乙型肝炎病毒感染的 2-氧代-6,7-二氢苯并[a]喹嗪-3-甲酸衍生物
|
WO2016161268A1
(en)
|
2015-04-01 |
2016-10-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antviral agents
|
JP6462155B2
(ja)
|
2015-05-04 |
2019-01-30 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
B型肝炎ウイルス感染症の治療用のHBsAg(HBV表面抗原)及びHBV DNA産生の阻害剤としてのテトラヒドロピリドピリミジン類及びテトラヒドロピリドピリジン類
|
US10738035B2
(en)
|
2015-05-13 |
2020-08-11 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|
WO2017011552A1
(en)
|
2015-07-13 |
2017-01-19 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antiviral agents
|
EP3325477B1
(en)
|
2015-07-21 |
2019-05-01 |
H. Hoffnabb-La Roche Ag |
Novel tricyclic 4-pyridone-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis b virus infection
|
US10301255B2
(en)
|
2015-07-22 |
2019-05-28 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|
WO2017017042A1
(en)
|
2015-07-27 |
2017-02-02 |
F. Hoffmann-La Roche Ag |
Novel tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis b virus infection
|
WO2017017043A1
(en)
|
2015-07-28 |
2017-02-02 |
F. Hoffmann-La Roche Ag |
Novel 6,7-dihydropyrido[2,1-a]phthalazin-2-ones for the treatment and prophylaxis of hepatitis b virus infection
|
JP6723254B2
(ja)
|
2015-10-05 |
2020-07-15 |
富士フイルム富山化学株式会社 |
抗b型肝炎ウイルス剤
|
US10253030B2
(en)
|
2015-11-04 |
2019-04-09 |
Qilu Pharmaceutical Co., Ltd. |
Crystal form, preparation method and intermediate of dihydropyrido ring compound
|
US10280175B2
(en)
|
2016-02-02 |
2019-05-07 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|
BR112018016842A2
(pt)
|
2016-02-19 |
2018-12-26 |
Novartis Ag |
compostos de piridona tetracíclica como antivirais
|
EP3426245B1
(en)
|
2016-03-07 |
2022-12-14 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antiviral agents
|
EP3426656B1
(en)
|
2016-03-08 |
2021-05-12 |
Novartis AG |
Tricyclic compounds useful to treat orthomyxovirus infections
|
IL307931A
(en)
|
2016-04-15 |
2023-12-01 |
Epizyme Inc |
Amine-substituted aryl or heteroaryl compounds as EHMT1 and EHMT2 inhibitors
|
BR102017010009A2
(pt)
|
2016-05-27 |
2017-12-12 |
Gilead Sciences, Inc. |
Compounds for the treatment of hepatitis b virus infection
|
KR20190016544A
(ko)
|
2016-06-10 |
2019-02-18 |
바이엘 파마 악티엔게젤샤프트 |
방사성-제약 복합체
|
BR112018075465A2
(pt)
|
2016-06-10 |
2019-03-19 |
Enanta Pharmaceuticals, Inc. |
agentes antivirais de hepatite b
|
JOP20170131B1
(ar)
|
2016-06-10 |
2021-08-17 |
Lilly Co Eli |
مركبات 1-تيترا هيدروبيرانييل كاربونيل -2،3-ديهيدرو -1 h- اندول لعلاج السرطان
|
FR3052452B1
(fr)
|
2016-06-10 |
2018-06-22 |
Les Laboratoires Servier |
Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
AU2017277732B2
(en)
|
2016-06-10 |
2021-06-17 |
Les Laboratoires Servier |
New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
|
WO2017216685A1
(en)
|
2016-06-16 |
2017-12-21 |
Novartis Ag |
Pentacyclic pyridone compounds as antivirals
|
WO2017216686A1
(en)
|
2016-06-16 |
2017-12-21 |
Novartis Ag |
8,9-fused 2-oxo-6,7-dihydropyrido-isoquinoline compounds as antivirals
|
MA45496A
(fr)
|
2016-06-17 |
2019-04-24 |
Hoffmann La Roche |
Molécules d'acide nucléique pour la réduction de l'arnm de padd5 ou pad7 pour le traitement d'une infection par l'hépatite b
|
JP6821716B2
(ja)
|
2016-06-29 |
2021-01-27 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
B型肝炎ウイルス感染の処置および予防のための新規のジヒドロピロロピリミジン
|
JP6742452B2
(ja)
|
2016-06-29 |
2020-08-19 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
Hbv感染の処置および予防のための新規のテトラヒドロピリドピリミジン
|
WO2018019297A1
(zh)
|
2016-07-29 |
2018-02-01 |
银杏树药业(苏州)有限公司 |
异喹啉酮类化合物及其制备抗病毒药物的应用
|
CN109715624B
(zh)
|
2016-07-29 |
2022-08-16 |
广州麓鹏制药有限公司 |
用于治疗hbv感染的新颖治疗剂
|
WO2018047109A1
(en)
|
2016-09-09 |
2018-03-15 |
Novartis Ag |
Polycyclic pyridone compounds as antivirals
|
TW201819380A
(zh)
|
2016-10-18 |
2018-06-01 |
瑞士商諾華公司 |
作為抗病毒劑之稠合四環吡啶酮化合物
|
CN109863145B
(zh)
|
2016-11-03 |
2022-04-12 |
豪夫迈·罗氏有限公司 |
用于治疗和预防乙型肝炎病毒感染的新的四氢异喹啉和四氢二氮杂萘化合物
|
JP7068295B2
(ja)
|
2016-11-03 |
2022-05-16 |
エフ.ホフマン-ラ ロシュ アーゲー |
B型肝炎ウイルス感染症の処置及び予防のための新規なテトラヒドロピリドピリミジン
|
WO2018083081A1
(en)
|
2016-11-03 |
2018-05-11 |
F. Hoffmann-La Roche Ag |
Novel tetrahydropyridopyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
TWI794190B
(zh)
|
2016-11-07 |
2023-03-01 |
加拿大商愛彼特生物製藥公司 |
含有取代的吡啶酮之三環化合物及其使用方法
|
WO2018087345A1
(en)
|
2016-11-14 |
2018-05-17 |
F. Hoffmann-La Roche Ag |
COMBINATION THERAPY OF AN HBsAg INHIBITOR, A NUCLEOS(T)IDE ANALOGUE AND AN INTERFERON
|
BR112019013371A2
(pt)
|
2017-01-06 |
2019-12-10 |
Rivus Pharmaceuticals Inc |
novos derivados de fenila
|
CN109369640B
(zh)
|
2017-01-13 |
2020-03-27 |
苏州爱科百发生物医药技术有限公司 |
一种二氢异喹啉类化合物的制备方法
|
JOP20180008A1
(ar)
|
2017-02-02 |
2019-01-30 |
Gilead Sciences Inc |
مركبات لعلاج إصابة بعدوى فيروس الالتهاب الكبدي b
|
WO2018154466A1
(en)
|
2017-02-21 |
2018-08-30 |
Glaxosmithkline Intellectual Property Development Limited |
Dihydroquinolizinones as antivirals
|
CN106928245B
(zh)
|
2017-03-06 |
2019-06-11 |
河南春风医药科技有限公司 |
一种喹嗪酮类化合物及其制备方法和应用
|
CN106928215B
(zh)
|
2017-03-06 |
2019-03-22 |
河南春风医药科技有限公司 |
一种喹嗪酮类化合物的制备方法
|
HUE055170T2
(hu)
|
2017-03-09 |
2021-11-29 |
Fujian Cosunter Pharmaceutical Co Ltd |
Hepatitis-B vírus felszíni antigén inhibitor
|
BR112019020401A2
(pt)
|
2017-03-31 |
2020-04-22 |
Fujifilm Corp |
composto 4-piridona ou seu sal, e composição farmacêutica e formulação que inclui o mesmo
|
CN108727378A
(zh)
|
2017-04-19 |
2018-11-02 |
银杏树药业(苏州)有限公司 |
新型异喹啉类化合物及其医药用途
|
AR111419A1
(es)
|
2017-04-27 |
2019-07-10 |
Novartis Ag |
Compuestos fusionados de indazol piridona como antivirales
|
CA3060121C
(en)
|
2017-04-28 |
2022-08-16 |
Qilu Pharmaceutical Co., Ltd. |
Polymorphic form of compound, preparation method and use thereof
|
CN108530449B
(zh)
|
2017-05-22 |
2021-05-07 |
河南春风医药科技有限公司 |
用于治疗或预防乙型肝炎病毒感染的化合物及其制备方法与应用
|
CN110066278B
(zh)
|
2017-06-01 |
2021-06-08 |
广东东阳光药业有限公司 |
稠合三环类化合物及其在药物中的应用
|
BR112020004112A2
(pt)
|
2017-08-28 |
2020-09-24 |
Enanta Pharmaceuticals, Inc. |
agentes antiviras da hepatite b
|
AU2018344926A1
(en)
|
2017-10-05 |
2020-04-16 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds
|
US20210079015A1
(en)
|
2017-11-17 |
2021-03-18 |
Novartis Ag |
Novel dihydroisoxazole compounds and their use for the treatment of hepatitis b
|
EP3694856B1
(en)
|
2017-11-22 |
2023-10-25 |
Sunshine Lake Pharma Co., Ltd. |
Fused tricyclic compounds and uses thereof in medicine
|
GB201720163D0
(en)
|
2017-12-04 |
2018-01-17 |
Galapagos Nv |
Novel compounds and pharmaceutical compositions thereof for the treatment of hepatitis B
|
TW201927789A
(zh)
|
2017-12-06 |
2019-07-16 |
美商因那塔製藥公司 |
B型肝炎抗病毒試劑
|
TW201936192A
(zh)
|
2017-12-06 |
2019-09-16 |
美商因那塔製藥公司 |
B 型肝炎抗病毒試劑
|
JP2021507906A
(ja)
|
2017-12-20 |
2021-02-25 |
ノバルティス アーゲー |
抗ウイルス剤としての融合三環式ピラゾロ−ジヒドロピラジニル−ピリドン化合物
|
EP3732177B1
(en)
|
2017-12-28 |
2021-11-17 |
F. Hoffmann-La Roche AG |
Dihydropyrimidinylthiazole for the treatment and prophylaxis of hepatitis b virus infection
|
WO2019143902A2
(en)
|
2018-01-22 |
2019-07-25 |
Enanta Pharmaceuticals, Inc. |
Substituted heterocycles as antiviral agents
|
WO2019166951A1
(en)
|
2018-02-28 |
2019-09-06 |
Novartis Ag |
Indole-2-carbonyl compounds and their use for the treatment of hepatitis b
|
WO2019191166A1
(en)
|
2018-03-29 |
2019-10-03 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antiviral agents
|
KR20210065965A
(ko)
|
2018-09-21 |
2021-06-04 |
이난타 파마슈티칼스, 인코포레이티드 |
항바이러스제로서 작용화된 헤테로사이클
|
CA3119973A1
(en)
|
2018-11-21 |
2020-05-28 |
Enanta Pharmaceuticals, Inc. |
Functionalized heterocycles as antiviral agents
|
TW202033523A
(zh)
|
2019-01-17 |
2020-09-16 |
美商愛彼特生物製藥股份有限公司 |
經取代的多環羧酸、其類似物及使用其之方法
|